2018
DOI: 10.1590/abd1806-4841.20188039
|View full text |Cite
|
Sign up to set email alerts
|

Dermoscopic findings of pseudoxanthomatous mastocytosis localized on vulva

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 5 publications
(17 reference statements)
0
3
0
Order By: Relevance
“…Sporadic reports describe the dermoscopy features of other genital disorders in both sexes, such as clear cell acanthoma, 121 eruptive vellus hair cysts, 122 lichen aureus, 123 median raphe cyst, 124 metastasis, 29 Mondor’s disease, 125 neutrophilic sebaceous adenitis, 126 Paget’s disease, 127 porokeratosis ptychotropica, 128 postinflammatory pigmentation, 16,17 pseudoxanthomatous mastocytosis, 129 purpura, 16 tick bite, 130,131 and verruciform xanthoma 132–134 …”
Section: Resultsmentioning
confidence: 99%
“…Sporadic reports describe the dermoscopy features of other genital disorders in both sexes, such as clear cell acanthoma, 121 eruptive vellus hair cysts, 122 lichen aureus, 123 median raphe cyst, 124 metastasis, 29 Mondor’s disease, 125 neutrophilic sebaceous adenitis, 126 Paget’s disease, 127 porokeratosis ptychotropica, 128 postinflammatory pigmentation, 16,17 pseudoxanthomatous mastocytosis, 129 purpura, 16 tick bite, 130,131 and verruciform xanthoma 132–134 …”
Section: Resultsmentioning
confidence: 99%
“…Finally, an instance of pseudoxanthomatous localised mastocytosis involving the vulva showed pigmented streaks with radial distribution surrounding hair follicles, and this pattern was considered pathognomonic by the authors [ 6 ].…”
Section: Resultsmentioning
confidence: 99%
“…According to the current World Health Organization (WHO) classification, CM is divided into three forms: maculopapular cutaneous mastocytosis (MPCM) (including clinical subtypes previously known as urticaria pigmentosa [UP] and telangiectasia macularis eruptiva perstans [TMEP]), diffuse cutaneous mastocytosis (DCM), and mastocytoma of the skin [ 5 ]. Other clinical variants of CM have been described, e.g., nodular mastocytosis, plaque-type mastocytosis, pseudoangiomatous xanthelasmoid mastocytosis, and pseudoxanthomatous localised mastocytosis, though they are no longer recognised as separate entities but as clinical subtypes of either MPCM or mastocytoma based on the number of the lesions (>5 MPCM and ≤5 mastocytoma) [ 2 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. The diagnosis of cutaneous mastocytosis is generally based on clinical assessment (presentation of cutaneous lesions, positive Darier’s sign, and symptoms arising from mediator release) in association with additional investigations, such as histopathological, immunohistochemical, and sometimes genetic assessment.…”
Section: Introductionmentioning
confidence: 99%